What Outset Medical Co. Shareholders Need to Know About the Lead Plaintiff Process Under the PSLRA

Contact Outset Medical loss lawyer Timothy L. Miles today about an Outset Medical class action lawsuit,

The Outset Medical class action lawsuit seeks to represent purchasers or acquirers of Outset Medical, Inc. (NASDAQ: OM) common stock between September 15, 2020 and June 13, 2022, inclusive (the “Class Period”).  The Outset Medical class action lawsuit – captioned Plymouth County Retirement Association v. Outset Medical, Inc., No. 22-cv-04016 (N.D. Cal.) – charges Outset Medical and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
​
If you suffered losses in Outset Medical stock and wish to serve as lead plaintiff of the Outset Medical class action lawsuit, please provide your information here.  You can also contact Outset Medical Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected].  Lead plaintiff motions for the Outset Medical class action lawsuit must be filed with the court no later than September 6, 2022.

The Lead Plaintiff Process in the Outset Medical Class Action Lawsuit

The Private Securities Litigation Reform Act of 1995 (“PSLRA) permits any investor who purchased and suffered losses in Outset Medical stock to seek appointment as lead plaintiff in the Outset Medical class action lawsuit. Under the PSLRA, after a complaint is filed, a plaintiff has no later than 20 days to circulate notice to shareholders about the filing of the complaint notifying shareholders that “not later than 60 days after the date on which the notice is published, any member of the purported class may move the court to serve as lead plaintiff of the purported class.” 15 U.S. Code § 78u–4(a)(3)(A)(i)-(iii.).  Thus, pursuant to the PSLRA, Lead plaintiff motions for the Outset Medical class action lawsuit must be filed with the court no later than September 6, 2022.
​
​ A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.  15 U.S. Code § 78u–4(a)(3)(B)(iii)(I)(bb)-(cc). A lead plaintiff is a fiduciary and acts on behalf of all other class members in directing the class action lawsuit.  The lead plaintiff can select a law firm of its choice to litigate the class action lawsuit.  An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. If you suffered losses in Outset Medical stock, and have further questions, contact Outset Medical Stock Loss Lawyer Timothy L. Miles today.Lead plaintiff motions for the Outset Medical class Action Must Be Filed With the Court no Later than September 6, 2022.

Contact an Outset Medical Stock Loss Lawyer if You Suffered Losses in Outset Medical Stock

​If you suffered losses in Outset Medical stock, contact Outset Medical loss lawyer Timothy L. Miles today about an Outset Medical class action lawsuit, and see what an Outset Medical stock loss Lawyer can do for you.

Timothy L. Miles, Esq.

A TG Therapeutics Stock Loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation. A TG Therapeutics Stock Loss Lawyer focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, if they have lost money due to mistakes, incompetence, or fraud by an investment professional. While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discovery every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct, such as a TG Therapeutics Stock Loss Lawyer who will work to recover the losses you sustained through a TG Therapeutics ​​Class Action lawsuit.​